Authors

• Irzal Hadžibegović — Klinička bolnica Dubrava, Zagreb, Hrvatska — ORCID: 0000-0002-3768-9134
• Ante Lisičić — Klinička bolnica Dubrava, Zagreb, Hrvatska — ORCID: 0000-0002-4365-9652
• Petra Vitlov — Klinička bolnica Dubrava, Zagreb, Hrvatska — ORCID: 0000-0001-6983-1409
• Boris Starčević — Klinička bolnica Dubrava, Zagreb, Hrvatska — ORCID: 0000-0002-3090-2772

Abstract

**Background**: Left ventricular non-compaction cardiomyopathy (LVNCC) can be associated with left ventricle (LV) dilation or hypertrophy, systolic or diastolic dysfunction, or both. (1) Heart failure (HF) symptoms and presentations vary, and some patients may be asymptomatic. Affected individuals are at risk of left and/or right ventricular HF, embolization and malignant arrhythmias when device implantation is necessary. One study showed that LVNCC patients showed better response to resynchronization therapy. **Case presentation**: 36-year-old previously healthy male was admitted because of acute left ventricular failure in NYHA III/IV class. ECG showed left bundle branch block with QRS duration of 168 ms. Bedside echocardiography revealed a dilated LV (71 mm in end-diastole) with estimated ejection fraction (EF) of 26%, moderate mitral regurgitation, moderate left atrial enlargement, moderate pulmonary hypertension with indirect signs of preserved right ventricular function. Standard therapy with diuretics, ACE inhibitors, beta-blocker, mineralocorticoid receptor antagonist and prophylactic dose of enoxaparine was introduced. After initial recompenzation he suffered from an acute embolization of the right superficial femoral artery. Successful embolectomy was performed and therapeutic doses of enoxaparine were introduced with warfarin overlap. Control echocardiography revealed no residual thrombi in the LV, that showed trabeculization, but without clear echocardiographic criteria for LVNCC. Warfarin was titrated to optimal INR value, and after optimization of medical therapy he was discharged in NYHA II class and scheduled for MSCT coronary angiography and cardiac MR. Ischemic heart disease was excluded and cardiac MR confirmed LVNCC with EF of 24%. He was scheduled for CRT-D implantation under warfarin in therapeutic range. All three electrodes were implanted with optimal sensing and stimulation values and during resynchronization he had high R wave in V1 and V2 lead, with echocardiographic signs of a super-responder. After 9 months of follow-up he was in NYHA I class without loop-diuretics, and with 100% successful biventricular pacing and no ventricular ectopy detected after introduction of sacubitril/valsartan. **Conclusion**: Patients with LVNCC and appropriate criteria appear to be great responders to resynchronization with chances of optimal reverse remodeling.

Keywords

left ventricular non-compaction cardiomyopathy, resynchronisation

DOI

Literature

1. Bertini M, Ziacchi M, Biffi M, Biagini E, Rocchi G, Martignani C, et al. Effects of cardiac resynchronisation therapy on dilated cardiomyopathy with isolated ventricular non-compaction. Heart. 2011 Feb;97(4):295–300. https://doi.org/10.1136/hrt.2010.211607